General Information of Target

Target ID LDTP15563
Target Name Aflatoxin B1 aldehyde reductase member 4 (AKR7L)
Gene Name AKR7L
Gene ID 246181
Synonyms
AFAR3; AKR7A4; Aflatoxin B1 aldehyde reductase member 4; EC 1.-.-.-; AFB1 aldehyde reductase 3; AFB1-AR 3; Aldoketoreductase 7-like
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MNPLLILAFVGAAVAVPFDDDDKIVGGYTCEENSVPYQVSLNSGSHFCGGSLISEQWVVS
AGHCYKPHIQVRLGEHNIEVLEGNEQFINAAKIIRHPKYNRIILNNDIMLIKLSTPAVIN
AHVSTISLPTAPPAAGTECLISGWGNTLSSGADYPDELQCLDAPVLTQAKCKASYPLKIT
SNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGIVSWGYGCAQKRRPGVYTKVYNYVDWIK
DTIAANS
Target Bioclass
Enzyme
Family
Aldo/keto reductase family, Aldo/keto reductase 2 subfamily
Function
Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen.
Uniprot ID
Q8NHP1
HGNC ID
HGNC:24056

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 6 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
DBIA
 Probe Info 
C128(1.88)  LDD3333  [1]
HHS-475
 Probe Info 
Y197(0.80); Y211(0.85)  LDD0264  [2]
TFBX
 Probe Info 
C186(2.19)  LDD0314  [3]
HHS-465
 Probe Info 
Y197(10.00); Y211(10.00)  LDD2237  [4]
ATP probe
 Probe Info 
K208(0.00); K210(0.00)  LDD0199  [5]
IA-alkyne
 Probe Info 
C186(0.00); C128(0.00)  LDD0162  [6]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0563  Abegg_cp(+)-11 HeLa C186(2.19)  LDD0314  [3]
 LDCM0116  HHS-0101 DM93 Y197(0.80); Y211(0.85)  LDD0264  [2]
 LDCM0117  HHS-0201 DM93 Y197(0.99); Y211(1.08)  LDD0265  [2]
 LDCM0118  HHS-0301 DM93 Y211(0.75); Y197(0.79)  LDD0266  [2]
 LDCM0119  HHS-0401 DM93 Y211(0.92); Y197(1.06)  LDD0267  [2]
 LDCM0120  HHS-0701 DM93 Y197(0.61); Y211(0.98)  LDD0268  [2]
 LDCM0022  KB02 AU565 C128(1.28)  LDD2265  [1]
 LDCM0023  KB03 AU565 C128(1.77)  LDD2682  [1]
 LDCM0024  KB05 MOLM-13 C128(1.88)  LDD3333  [1]

References

1 DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22.
Mass spectrometry data entry: PXD047840
2 Discovery of a Cell-Active SuTEx Ligand of Prostaglandin Reductase 2. Chembiochem. 2021 Jun 15;22(12):2134-2139. doi: 10.1002/cbic.202000879. Epub 2021 Apr 29.
3 Chemoproteomic Profiling by Cysteine Fluoroalkylation Reveals Myrocin G as an Inhibitor of the Nonhomologous End Joining DNA Repair Pathway. J Am Chem Soc. 2021 Dec 8;143(48):20332-20342. doi: 10.1021/jacs.1c09724. Epub 2021 Nov 24.
Mass spectrometry data entry: PXD029255
4 Global targeting of functional tyrosines using sulfur-triazole exchange chemistry. Nat Chem Biol. 2020 Feb;16(2):150-159. doi: 10.1038/s41589-019-0404-5. Epub 2019 Nov 25.
5 Targeted Proteomic Approaches for Proteome-Wide Characterizations of the AMP-Binding Capacities of Kinases. J Proteome Res. 2022 Aug 5;21(8):2063-2070. doi: 10.1021/acs.jproteome.2c00225. Epub 2022 Jul 12.
6 SP3-FAIMS Chemoproteomics for High-Coverage Profiling of the Human Cysteinome*. Chembiochem. 2021 May 14;22(10):1841-1851. doi: 10.1002/cbic.202000870. Epub 2021 Feb 18.
Mass spectrometry data entry: PXD023056 , PXD023059 , PXD023058 , PXD023057 , PXD023060